Home / World Marketplace / Global Corporate Affairs / Archive by category Survey and Research (Page 75)

Archive by category Survey and Research

Novotech Publishes Analyst Report on Cystic Fibrosis Clinical Trial Landscape to Inform Biotech Research Planning

BOSTON, Apr. 10 (Korea Bizwire) — Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released a comprehensive research report entitled Cystic Fibrosis – Global Clinical Trial Landscape. The report presents a data-backed review of the Cystic Fibrosis [...]

BPM Partners and BARC Join Forces to Deliver First of Its Kind Global CPM Priorities and Trends Research Report

Report Will Combine Data from the 2024 BPM Pulse and The Planning Survey 24 STAMFORD, Conn. and WÜRZBURG, Germany, April 10, 2024 (Korea Bizwire) – BPM Partners, the leading independent authority on business performance management (BPM/CPM/EPM), and BARC, a leading analyst firm for data & analytics and enterprise software, today announced plans to release a new research [...]

Wistar Scientists Identify Pro-aging ‘Sugar Signature’ in the Blood of People Living with HIV

The Abdel-Mohsen lab findings shed light on how sugar molecules in the blood of people living with HIV may accelerate biological aging PHILADELPHIA, PA, April 10, 2024 (Korea Bizwire) – The Wistar Institute’s associate professor Mohamed Abdel-Mohsen, Ph.D., along with his team and collaborators, has identified sugar abnormalities in the blood that may promote biological aging and [...]

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA and Philips Respironics have now reached final agreement on the consent decree with the DOJ and FDA. As previously stated: The consent decree primarily focuses on Philips Respironics’ business operations in the US. [...]

AACSB Announces 2024 Class of Influential Leaders

Ninth annual initiative recognizes 22 impactful business school researchers TAMPA, Fla., April 08, 2024 (Korea Bizwire) – AACSB International (AACSB)—the world’s largest business education alliance—announces today its 2024 Class of Influential Leaders, a group of 22 AACSB-accredited business school faculty demonstrating impact through their research. Now in its ninth year, AACSB’s Influential Leaders member spotlight program highlights the [...]

Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting

VANCOUVER, British Columbia, April 08, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced five presentations including new data from its preclinical development-stage programs at the 2024 American Association for Cancer Research (AACR) [...]

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer

SHANGHAI, China, April 07, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (“NMPA”) has approved the supplemental new drug application (“sNDA”) for toripalimab (product code: JS001) [...]

Samsung Bioepis Initiates Phase 3 Clinical Trial for SB27, Proposed Biosimilar to Keytruda (Pembrolizumab)

INCHEON, Korea, April 05, 2024 (Korea Bizwire) – Samsung Bioepis Co., Ltd. today announced the initiation of Phase 3 clinical trial for SB27, the company’s proposed biosimilar referencing Keytrudai (pembrolizumab). The Phase 3 clinical trial for SB27 is a randomized, double-blind, parallel group, multicenter studyii to compare the efficacy, safety, pharmacokinetics, and immunogenicity between SB27 and Keytruda [...]

QuantalRF Launches Groundbreaking 5-7 GHz Wi-Fi 7 Front-End IC in CMOS SOI

ZÜRICH, Switzerland, April 04, 2024 (Korea Bizwire) – QuantalRF, the pioneering developer of RF semiconductor and antenna solutions, is proud to announce the launch of its innovative QWX27105 single-chip 5-7 GHz front-end IC, its first release in the Elementum™ family of Wi-Fi 7 products. This cutting-edge product integrates all RF front-end components into an ultra-compact [...]

Schneider Electric Announces Global Winners of Second Edition of Its Sustainability Impact Awards

- 12 global partners, customers, and suppliers recognized for outstanding performance in either decarbonizing their own operations or decarbonizing the operations of their customers Schneider Electric, the leader in the digital transformation of energy management and automation, today announced the global winners of the latest Schneider Electric Sustainability Impact Awards. The winners were commended for their pioneering decarbonization efforts, both within [...]